Comparison of the absorption of calcium carbonate and calcium citrate after roux-en-Y gastric bypass

P. Tondapu, D. Provost, B. Adams-Huet, T. Sims, C. Chang, K. Sakhaee

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

Introduction: Roux-en-Y gastric bypass (RYGB) restricts food intake. Consequently, patients consume less calcium. In addition, food no longer passes through the duodenum, the main site of calcium absorption. Therefore, calcium absorption is significantly impaired. The goal of this study is to compare two common calcium supplements in gastric bypass patients. Method: Nineteen patients were enrolled in a randomized, double-blinded, crossover study comparing the absorption of calcium from calcium carbonate and calcium citrate salts. Serum and urine calcium levels were assessed for peak values (C max) and cumulative calcium increment (area under the curve [AUC]). Serum PTH was assessed for minimum values (PTHmin) and cumulative PTH decrement (AUC). Statistical analysis was performed using a repeated analysis of variance model. Results: Eighteen subjects completed the study. Calcium citrate resulted in a significantly higher serum C max (9.4+0.4 mg/dl vs. 9.2+0.3 mg/dl, p=0.02) and serum AUC (55+2 mg/dl vs. 54+2 mg/dl, p=0.02). Calcium citrate resulted in a significantly lower PTHmin (24+11 pg/ml vs. 30+13 pg/ml, p=0.01) and a higher AUC (-32+51 pg/ml vs. -3+56 pg/ml, p=0.04). There was a non-significant trend for higher urinary AUC in the calcium citrate group (76.13+36.39 mg/6 h vs. 66.04+40.82, p=0.17). Conclusion: Calcium citrate has superior bioavailability than calcium carbonate in RYGB patients.

Original languageEnglish (US)
Pages (from-to)1256-1261
Number of pages6
JournalObesity Surgery
Volume19
Issue number9
DOIs
StatePublished - Sep 2009

Fingerprint

Calcium Citrate
Gastric Bypass
Calcium Carbonate
Calcium
Area Under Curve
Serum
Duodenum
Cross-Over Studies
Biological Availability
Analysis of Variance
Salts
Eating
Urine
Food

Keywords

  • Calcium carbonate
  • Calcium citrate
  • Obesity
  • Roux-en-Y gastric bypass

ASJC Scopus subject areas

  • Surgery
  • Endocrinology, Diabetes and Metabolism
  • Nutrition and Dietetics

Cite this

Comparison of the absorption of calcium carbonate and calcium citrate after roux-en-Y gastric bypass. / Tondapu, P.; Provost, D.; Adams-Huet, B.; Sims, T.; Chang, C.; Sakhaee, K.

In: Obesity Surgery, Vol. 19, No. 9, 09.2009, p. 1256-1261.

Research output: Contribution to journalArticle

@article{cc0a0472fcd74146bc9e0655febda89c,
title = "Comparison of the absorption of calcium carbonate and calcium citrate after roux-en-Y gastric bypass",
abstract = "Introduction: Roux-en-Y gastric bypass (RYGB) restricts food intake. Consequently, patients consume less calcium. In addition, food no longer passes through the duodenum, the main site of calcium absorption. Therefore, calcium absorption is significantly impaired. The goal of this study is to compare two common calcium supplements in gastric bypass patients. Method: Nineteen patients were enrolled in a randomized, double-blinded, crossover study comparing the absorption of calcium from calcium carbonate and calcium citrate salts. Serum and urine calcium levels were assessed for peak values (C max) and cumulative calcium increment (area under the curve [AUC]). Serum PTH was assessed for minimum values (PTHmin) and cumulative PTH decrement (AUC). Statistical analysis was performed using a repeated analysis of variance model. Results: Eighteen subjects completed the study. Calcium citrate resulted in a significantly higher serum C max (9.4+0.4 mg/dl vs. 9.2+0.3 mg/dl, p=0.02) and serum AUC (55+2 mg/dl vs. 54+2 mg/dl, p=0.02). Calcium citrate resulted in a significantly lower PTHmin (24+11 pg/ml vs. 30+13 pg/ml, p=0.01) and a higher AUC (-32+51 pg/ml vs. -3+56 pg/ml, p=0.04). There was a non-significant trend for higher urinary AUC in the calcium citrate group (76.13+36.39 mg/6 h vs. 66.04+40.82, p=0.17). Conclusion: Calcium citrate has superior bioavailability than calcium carbonate in RYGB patients.",
keywords = "Calcium carbonate, Calcium citrate, Obesity, Roux-en-Y gastric bypass",
author = "P. Tondapu and D. Provost and B. Adams-Huet and T. Sims and C. Chang and K. Sakhaee",
year = "2009",
month = "9",
doi = "10.1007/s11695-009-9850-6",
language = "English (US)",
volume = "19",
pages = "1256--1261",
journal = "Obesity Surgery",
issn = "0960-8923",
publisher = "Springer New York",
number = "9",

}

TY - JOUR

T1 - Comparison of the absorption of calcium carbonate and calcium citrate after roux-en-Y gastric bypass

AU - Tondapu, P.

AU - Provost, D.

AU - Adams-Huet, B.

AU - Sims, T.

AU - Chang, C.

AU - Sakhaee, K.

PY - 2009/9

Y1 - 2009/9

N2 - Introduction: Roux-en-Y gastric bypass (RYGB) restricts food intake. Consequently, patients consume less calcium. In addition, food no longer passes through the duodenum, the main site of calcium absorption. Therefore, calcium absorption is significantly impaired. The goal of this study is to compare two common calcium supplements in gastric bypass patients. Method: Nineteen patients were enrolled in a randomized, double-blinded, crossover study comparing the absorption of calcium from calcium carbonate and calcium citrate salts. Serum and urine calcium levels were assessed for peak values (C max) and cumulative calcium increment (area under the curve [AUC]). Serum PTH was assessed for minimum values (PTHmin) and cumulative PTH decrement (AUC). Statistical analysis was performed using a repeated analysis of variance model. Results: Eighteen subjects completed the study. Calcium citrate resulted in a significantly higher serum C max (9.4+0.4 mg/dl vs. 9.2+0.3 mg/dl, p=0.02) and serum AUC (55+2 mg/dl vs. 54+2 mg/dl, p=0.02). Calcium citrate resulted in a significantly lower PTHmin (24+11 pg/ml vs. 30+13 pg/ml, p=0.01) and a higher AUC (-32+51 pg/ml vs. -3+56 pg/ml, p=0.04). There was a non-significant trend for higher urinary AUC in the calcium citrate group (76.13+36.39 mg/6 h vs. 66.04+40.82, p=0.17). Conclusion: Calcium citrate has superior bioavailability than calcium carbonate in RYGB patients.

AB - Introduction: Roux-en-Y gastric bypass (RYGB) restricts food intake. Consequently, patients consume less calcium. In addition, food no longer passes through the duodenum, the main site of calcium absorption. Therefore, calcium absorption is significantly impaired. The goal of this study is to compare two common calcium supplements in gastric bypass patients. Method: Nineteen patients were enrolled in a randomized, double-blinded, crossover study comparing the absorption of calcium from calcium carbonate and calcium citrate salts. Serum and urine calcium levels were assessed for peak values (C max) and cumulative calcium increment (area under the curve [AUC]). Serum PTH was assessed for minimum values (PTHmin) and cumulative PTH decrement (AUC). Statistical analysis was performed using a repeated analysis of variance model. Results: Eighteen subjects completed the study. Calcium citrate resulted in a significantly higher serum C max (9.4+0.4 mg/dl vs. 9.2+0.3 mg/dl, p=0.02) and serum AUC (55+2 mg/dl vs. 54+2 mg/dl, p=0.02). Calcium citrate resulted in a significantly lower PTHmin (24+11 pg/ml vs. 30+13 pg/ml, p=0.01) and a higher AUC (-32+51 pg/ml vs. -3+56 pg/ml, p=0.04). There was a non-significant trend for higher urinary AUC in the calcium citrate group (76.13+36.39 mg/6 h vs. 66.04+40.82, p=0.17). Conclusion: Calcium citrate has superior bioavailability than calcium carbonate in RYGB patients.

KW - Calcium carbonate

KW - Calcium citrate

KW - Obesity

KW - Roux-en-Y gastric bypass

UR - http://www.scopus.com/inward/record.url?scp=69249215435&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=69249215435&partnerID=8YFLogxK

U2 - 10.1007/s11695-009-9850-6

DO - 10.1007/s11695-009-9850-6

M3 - Article

VL - 19

SP - 1256

EP - 1261

JO - Obesity Surgery

JF - Obesity Surgery

SN - 0960-8923

IS - 9

ER -